Kura Oncology Doses First Patient in Phase 1 Clinical Trial of Menin-MLL Inhibitor KO-539 in Acute Myeloid Leukemia
September 16, 2019 07:30 ET
|
Kura Oncology, Inc.
– KO-539 is a first-in-class small molecule inhibitor of the menin-MLL interaction – – First-in-human trial to determine MTD, expand to genetic subgroups such as NPM1 – SAN DIEGO, Sept. 16, 2019 ...
Philips showcases integrated radiation oncology portfolio to provide a confident path to treatment at ASTRO 2019
September 12, 2019 09:00 ET
|
Royal Philips
September 12, 2019 IntelliSpace Radiation Oncology combines all the steps of the radiotherapy department’s workflow into one platform Amsterdam, the Netherlands and Chicago, U.S. –...
ARCA Biopharma President and CEO Dr. Michael Bristow to Present at HFSA 2019 Excellence in Translational Science Symposium
September 12, 2019 08:30 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Sept. 12, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
Auransa Announces CEO to Participate on Executive Leadership Panel at the 6th Annual Indy Big Data Conference
September 12, 2019 08:05 ET
|
Auransa
PALO ALTO, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical...
Dr Kristi Kuper Joins DoseMe as Director of Clinical Pharmacy
September 11, 2019 08:00 ET
|
Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced...
Syapse Appoints Fletcher Payne as Chief Financial Officer
September 10, 2019 08:00 ET
|
Syapse
SAN FRANCISCO, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Syapse, a company accelerating precision medicine through insights derived from its global health system network, today announced that Fletcher...
DNV GL Healthcare’s 2019 Symposium Returns To Company’s Roots, Focuses On Critical Healthcare Issue
September 05, 2019 10:10 ET
|
DNV GL Business Assurance USA, Inc.
MILFORD, OHIO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- DNV GL Healthcare’s 2019 Symposium will be held at the Hilton Cincinnati Netherland Plaza, November 6-8. Founded in the Cincinnati area just over...
Tempus Expands Its Management Team With the Appointment of Lauren Silvis as Senior Vice President of External Affairs
September 03, 2019 13:00 ET
|
Tempus
CHICAGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announced today the...
Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib in HRAS Mutant Urothelial Carcinoma
September 03, 2019 07:30 ET
|
Kura Oncology, Inc.
– Confirmed objective responses achieved in five of 13 evaluable patients – – Primary endpoint met prior to completion of enrollment with four patients experiencing progression-free survival greater...
Kura Oncology to Participate in Two Upcoming Investor Conferences
August 29, 2019 07:30 ET
|
Kura Oncology, Inc.
SAN DIEGO, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of...